Hanmi Pharm. Co., Ltd. (KRX: 128940)

Market Cap	4.11T
Revenue (ttm)	1.57T
Net Income (ttm)	184.38B
Shares Out	12.68M
EPS (ttm)	14,533.91
PE Ratio	22.33
Forward PE	22.05
Dividend	500.00 (0.15%)
Ex-Dividend Date	Jun 27, 2024

Volume	12,679
Open	330,000
Previous Close	328,500
Day's Range	321,000 - 330,000
52-Week Range	258,000 - 377,000
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About Hanmi Pharm.

Hanmi Pharm. Co., Ltd., a biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally. It focuses on research areas with high unmet medical needs, including obesity, metabolism, oncology, and rare diseases. The company was founded in 1973 and is based in Hwaseong-si, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1973
• Employees: 2,273
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 128940

Financial Performance

In 2023, Hanmi Pharm.'s revenue was 1.49 trillion, an increase of 11.97% compared to the previous year's 1.33 trillion. Earnings were 146.23 billion, an increase of 76.63%.